Thomas Kartika, MD

Publications

• Kartika T, Buitrago L, Li J, Cunningham-Rundles C, Coller BS. Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fc? receptor (Fc?R) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy. Res Pract Thromb Haemost. 2026 Jul;10(5):106841. PubMed PMID: 42602438
• Buitrago L, Menezes MR, Larson C, Li J, Kartika T, Banerjee P, Glickman F, Coller B. Unbiased high-throughput screening of drug-repurposing libraries identifies small-molecule inhibitors of clot retraction. Blood Adv. 2025 Mar 11;9(5):1049-1068. doi: 10.1182/bloodadvances.2024013810. PMID: 39374578; PMCID: PMC11909436.
• Kartika T, Mathews R, Migneco G, Bundy T, Kaempf AJ, Pfeffer M, DeLoughery TG, Moore K, Beardshear R, Oetken HJ, Case J, Hinds MT, McCarty OJT, Shatzel JJ, Zonies D, Zakhary B. Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin. Eur J Haematol. 2024 Apr;112(4):566-576. PubMed PMID: 38088062
• Kohs TCL, Weeder BR, Chobrutskiy BI, Kartika T, Moore KK, McCarty OJT, Zonies D, Zakhary B, Shatzel JJ. Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registry. J Thromb Thrombolysis. 2024 Mar;57(3):345-351. PubMed PMID: 38095743
• West MT, Goodyear SM, Hobbs EA, Kaempf A, Kartika T, Ribkoff J, Chun B, Mitri ZI. Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer. Oncologist. 2023 Aug 3;28(8):682-690. PubMed PMID: 36946994
• Mohinani A, Patel S, Tan V, Kartika T, Olson S, DeLoughery TG, Shatzel J. Desmopressin as a hemostatic and blood sparing agent in bleeding disorders. Eur J Haematol. 2023 May;110(5):470-479. PubMed PMID: 36656570
• Paquin AR, Oyogoa E, McMurry HS, Kartika T, West M, Shatzel JJ. The diagnosis and management of suspected lymphoma in general practice. Eur J Haematol. 2023 Jan;110(1):3-13. PubMed PMID: 36093749
• LaVasseur C, Mathews R, Wang JSH, Martens K, McMurry HS, Peress S, Sabile J, Kartika T, Oleson I, Lo JO, DeLoughery TG, McCarty OJT, Shatzel JJ. Estrogen-based hormonal therapy and the risk of thrombosis in COVID-19 patients. Eur J Haematol. 2023 Nov;111(5):678-686. PubMed PMID: 37519103
• Pfeffer MA, Martens K, Kartika T, McMurry H, Olson S, DeLoughery T, Shatzel JJ. Psychological toxicity in classical hematology. Eur J Haematol. 2023 Oct;111(4):516-527. PubMed PMID: 37455616
• Goel A, Khorana A, Kartika T, Gowda S, Tao DL, Thawani R, Shatzel JJ. Assessing the risk of thromboembolism in cancer patients receiving immunotherapy. Eur J Haematol. 2022 Apr;108(4):271-277. PubMed PMID: 34905252
• West MT, Kartika T, Paquin AR, Liederbauer E, Zheng TJ, Lane L, Thein K, Shatzel JJ. Thrombotic events in patients using cyclin dependent kinase 4/6 inhibitors, analysis of existing ambulatory risk assessment models and the potential influences of tumor specific risk factors. Curr Probl Cancer. 2022 Apr;46(2):100832. PubMed PMID: 35034766
• Thawani R, Kartika T, Elstrott B, Batiuk E, Tao D, Gowda S, Chen L, Lavasseur C, Tun N, Taflin NF, Shatzel J. Association of PD-L1 expression, tumor mutational burden and immunotherapy with venous thrombosis in patients with solid organ malignancies. Thromb Res. 2022 Sep;217:12-14. PubMed PMID: 35816991
• Tao DL, Kartika T, Tran A, Prasad V. Phase I trials and therapeutic intent in the age of precision oncology: What is a patient's chance of response?. Eur J Cancer. 2020 Nov;139:20-26. PubMed PMID: 32957010

Practice Locations

University of Colorado Cancer Center - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

Hemophilia and Thrombosis Center
13199 E Montview Blvd
Suite 100
Aurora, CO 80045
303-724-0724

Specialty Information

Specialties

• Hematology and Oncology
• Hematology, Board Certification (2025)
• Internal Medicine, Board Certification (2021)